Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Waste Management Shares Under Pressure Following Disappointing Earnings

Dieter Jaworski by Dieter Jaworski
October 31, 2025
in Earnings, Industrial, Value & Growth
0
Waste Management Stock
0
SHARES
25
VIEWS
Share on FacebookShare on Twitter

Waste Management, the North American waste management leader, faces investor skepticism after reporting third-quarter results that fell short of market expectations. The company’s downward revision of its full-year outlook has triggered a significant sell-off, raising questions about whether the stock’s decline has reached its bottom.

Market Reaction Reflects Earnings Miss

The immediate market response was decisive. Following the earnings release, the stock dropped 2.1% in after-hours trading, then extended losses with an additional 3.8% decline the following session. This downward movement pushed shares to a fresh 52-week low.

The quarterly performance revealed several concerning trends. Waste Management posted adjusted earnings of $1.98 per share, missing the anticipated range of $2.01 to $2.02. Revenue of $6.44 billion also came in below projections. Most notably, the company’s operating margin contracted substantially to 15.3%, down from 20.0% during the same period last year, indicating that cost increases are outpacing revenue growth and putting significant pressure on profitability.

Divergent Analyst Views Create Uncertainty

Despite the disappointing figures, equity researchers display surprising confidence in the company’s prospects. The average price target among analysts sits between $242.50 and $253.00, suggesting substantial upside potential from current trading levels.

Should investors sell immediately? Or is it worth buying Waste Management?

  • Citigroup maintained its “Buy” recommendation and actually raised its target price from $268 to $270
  • Stifel also kept its “Buy” rating but reduced its target from $252 to $236
  • Bank of America took a more cautious stance, downgrading the stock to “Hold” and cutting its price objective from $251 to $231

This divergence between analyst optimism and actual market performance highlights underlying skepticism. The elevated short interest of 22.72% further confirms that many market participants anticipate continued weakness.

Operational Strengths Amid Challenges

Not all operational metrics showed weakness. Waste Management’s core collection and landfill businesses demonstrated resilience:

  • Prices in the core business increased by 6.0% with a yield of 3.8%
  • Landfill volumes expanded by a solid 5.2%
  • The recycling division grew its operating EBITDA by 18% despite declining commodity prices
  • Free cash flow remains healthy, with full-year projections between $2.8 and $2.9 billion

However, significant headwinds persist. Falling recycling commodity prices and underperformance at WM Healthcare Solutions require management attention. The central question for investors remains whether Waste Management can execute a turnaround or if further downward pressure on the stock lies ahead.

Ad

Waste Management Stock: Buy or Sell?! New Waste Management Analysis from March 25 delivers the answer:

The latest Waste Management figures speak for themselves: Urgent action needed for Waste Management investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Waste Management: Buy or sell? Read more here...

Tags: Waste Management
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Pinduoduo Stock
Asian Markets

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

March 25, 2026
XPeng Stock
Asian Markets

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026
Unitedhealth Stock
Analysis

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026
Next Post
Rigetti Stock

Quantum Computing Stock Rigetti Faces Critical Test After Epic Rally

Jamf Holding Stock

Apple Management Specialist Jamf to Go Private in $2.2 Billion Acquisition

Nike Stock

Nike Shares Face Persistent Downturn Despite Solid Earnings

Recommended

Technology Blockchain Trading online

Analyst Reaffirms Bullish Outlook on CyberArk Software with 300 Price Target

2 years ago
Pepsi Stock

PepsiCo’s Leadership Shift Amid Market Headwinds

4 months ago
Nvidia Stock

Nvidia’s AI Dominance Faces Critical Test as Key Client Explores Alternatives

4 months ago
Palantir Stock

Palantir Shares Navigate Market Turbulence

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

Ocugen Shares Tumble Despite Positive Clinical Trial Results

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Trending

Pinduoduo Stock
Asian Markets

Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant

by SiterGedge
March 25, 2026
0

All eyes are on Pinduoduo this Wednesday as the company prepares to release its fourth-quarter 2025 financial...

XPeng Stock

XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch

March 25, 2026
Oracle Stock

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026
Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pinduoduo’s Upcoming Earnings: A Critical Test for the E-Commerce Giant
  • XPeng Achieves Profitability Milestone Amid Strategic Mexican Launch
  • Oracle’s Backlog Soars on Cloud and AI Contract Momentum

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com